CAS 1644502-33-9

BPI-15086

CAS: 1644502-33-9

BPI-15086 is an orally active, effective, irreversible inhibitor selective for mutations, targeting both EGFR and the T790M resistance mutation tyrosine kinase. It can be utilized in the study of non-small cell lung cancer.

Fórmula: C₂₉H₃₃ClN₈O₄

Cor e Forma: Solid

Peso molecular: 593.08

Ref: TM-T200004